From: Effect of multidisciplinary care on diabetic kidney disease: a retrospective cohort study
Outcome: 40% eGFR decline | Events | Patients | Person-days | Incidence ratea (95% CI) | Adjusted HR (95% CI) |
---|---|---|---|---|---|
Main analysis | |||||
 Non-MDC group | 679 | 4,575 | 5,005,934 | 1.36 (1.26–1.46) | Ref |
 MDC group | 150 | 1,039 | 921,928 | 1.63 (1.38–1.91) | 1.18 (0.99–1.41) |
Changing the definition of censoring | |||||
 Non-MDC group | 630 | 4,575 | 4,778,767 | 1.32 (1.22–1.43) | Ref |
 MDC group | 150 | 1,039 | 921,928 | 1.63 (1.38–1.91) | 1.21 (1.01–1.44) |
Changing the definition of the MDC and non-MDC groups | |||||
 Non-MDC group | 511 | 3,349 | 3,665,556 | 1.39 (1.28–1.52) | Ref |
 MDC group | 95 | 689 | 590,790 | 1.61 (1.30–1.97) | 1.18 (0.95–1.47) |
Setting an upper limit for the observation period of 3Â years | |||||
 Non-MDC group | 519 | 4,575 | 3,513,034 | 1.48 (1.35–1.61) | Ref |
 MDC group | 123 | 1,039 | 735,007 | 1.67 (1.39–2.00) | 1.14 (0.94–1.39) |
Changing the definition of landmark time to 2Â years | |||||
 Non-MDC group | 440 | 3,661 | 3,700,736 | 1.19 (1.08–1.31) | Ref |
 MDC group | 114 | 821 | 663,891 | 1.72 (1.42–2.06) | 1.41 (1.14–1.73) |
IPTW | |||||
 Non-MDC group | 1,258 | 8,758 | 9,635,373 | 1.31 (1.23–1.38) | Ref |
 MDC group | 151 | 1,046 | 925,496 | 1.63 (1.38–1.91) | 1.24 (1.00–1.53) |
Overlap weighting | |||||
 Non-MDC group | 1,258 | 8,758 | 9,635,373 | 1.31 (1.23–1.38) | Ref |
 MDC group | 151 | 1,046 | 925,496 | 1.63 (1.38–1.91) | 1.13 (0.94–1.35) |